돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 82044생성일: 2026년 10월 23일

Piperazine, hydrochloride (1:?)

Einecs 228-042-7 · Piperazine dihydrochloride · PIPERAZINE HYDROCHLORIDE HYDRATE · Piperazine/hydrochloric acid,(1:x) · Piperazine hydrochloride hydrate, 98% · Piperazine hydrochloride salt complex

https://huagongshe.com/ko/chemical/82044

Piperazine, hydrochloride (1:?) 분자 구조식

식별자 및 물리적 특성

CAS No.6094-40-2
분자식C4H11ClN2
평균 분자량122.6 g/mol
단동위원소 질량122.0610761 g/mol
SMILESC1CNCCN1.Cl
InChIKeyMSQACBWWAIBWIC-UHFFFAOYSA-N
PubChem CID82044
EC No.228-042-7
DTXSIDDTXSID2064739

화학 및 물리적 성질

극성 표면적24.1
수소 결합 공여자 수3
수소 결합 수용자 수2
회전 가능 결합 수0
무거운 원자 수7
형식 전하0
복잡도26
Color/FormCREAM COLORED CRYSTALLINE POWDERWHITE NEEDLESWhite to creamy colored needles or powder.
용해도SOLUBILITY IN WATER: 35% @ 0 °C, 41% @ 20 °C, 48% @ 50 °CINSOL IN ORGANIC SOLVENTS
DecompositionWhen heated to decomposition it emits very toxic fumes of nitrous oxide and hydrogen chloride.
Stability/Shelf LifeSTABLE @ TEMP TO 270 °C & IN NEUTRAL OR ACID MEDIAStability of piperazine can be accomplished by use of its simple salts, /including hydrochloride/, which are more stable than the piperazine base.
Other Experimental PropertiesSLIGHTLY HYGROSCOPIC82-83 °C /Monohydrate/
녹는점147-149°C
BRN3670129

안전 및 규제

GHS 분류DangerH315: Causes skin irritation [Warning Skin corrosion/irritation]H317: May cause an allergic skin reaction [Warning Sensitization, Skin]H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]H361fd: Suspected of damaging fertilitySuspected of damaging the unborn child [Warning Reproductive toxicity]H412: Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]P203, P233, P260, P261, P264, P264+P265, P271, P272, P273, P280, P284, P302+P352, P304+P340, P305+P351+P338, P318, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)
규제 정보Hazard Traits - Respiratory ToxicityAuthoritative List - EC Annex VI Resp. Sens. - Cat. 1Report - if used as a fragrance or flavor ingredient
FDA 요건Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended21 U.S.C. 321-392).
NIOSH RecommendationsRecommended Exposure Limit: 10 Hr Time-Weighted Avg: 5 mg/cu m.
Hazard Classes and CategoriesReproductive toxicity - category 2Eye irritation - category 2Skin irritation - category 2Respiratory sensitisation - category 1Hazardous to the aquatic environment (chronic) - category 3Skin sensitisation - category 1Repr. 2Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3
Hazardous Reactivities and IncompatibilitiesWater [Note: Slightly hygroscopic (i.e., absorbs moisture from the air)].
처리 방법SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Preventive MeasuresIf material not on fire and not involved in fire: Keep sparks, flames, and othersources of ignition away. Keep material out of water sources and sewers. Build dikes to contain flow as necessary. /Piperazine/Personnel protection: Avoid breathing vapors. Keep upwind. ... Avoid bodily contact with the material. ... Do not handle broken packages unless wearing appropriate personal protective equipment. Wash away any material which may have contacted the body with copious amounts of water or soap and water. If contact with the material anticipated, wear appropriate chemical protective clothing. /Piperazine/The worker should immediately wash the skin when it becomes contaminated.Work clothing that becomes wet or significantly contaminated should be removed and replaced.Workers whose clothing may have become contaminated should change into uncontaminated clothing before leaving the work premises.
Threshold Limit Values (TLV)8 hr Time Weighted Avg (TWA): 5 mg/cu m.Excursion Limit Recommendation: Excursions in worker exposure levels may exceed 3 times the TLV-TWA for no more than a total of 30 minutes during a work day, and under no circumstances should they exceed 5 times the TLV-TWA, provided that the TLV-TWA is not exceeded.
Personal Protective Equipment (PPE)Wear appropriate personal protective clothing to prevent skin contact.Wear appropriate eye protection to prevent eye contact.Eyewash fountains should be provided in areas where there is any possibility that workers could be exposed to the substancethis is irrespective of the recommendation involving the wearing of eye protection.Facilities for quickly drenching the body should be provided within the immediate work area for emergency use where there is a possibility of exposure. [Note: It is intended that these facilities provide a sufficient quantity or flow of water to quickly remove the substance from any body areas likely to be exposed. The actual determination of what constitutes an adequate quick drench facility depends on the specific circumstances. In certain instances, a deluge shower should be readily available, whereas in others, the availability of water from a sink or hose could be considered adequate.]
상호 작용IN ISOLATED FROG & RABBIT HEARTS PIPERAZINE PRODUCED BIPHASIC EFFECT WITH INITIAL NEG INOTROPIC ACTION FOLLOWED BY POS INOTROPIC ACTION. FORMER PHASE WAS ANTAGONIZED BY ATROPINE, HEXAMETHONIUM & DIGOXIN. DIRECT ACTION ON THE HEART IS SUGGESTED. /PIPERAZINE HYDROGEN CHLORIDE/
Human Toxicity Excerpts... SIDE EFFECTS ... INCL HEADACHES, NAUSEA, VOMITING, DIARRHEA, LETHARGY, TREMOR, INCOORDINATION, MUSCULAR WEAKNESS ... & VAGUE OCULAR DISTURBANCES. /PIPERAZINE SALTS/LOSS OF CONSCIOUSNESS, DYSARTHRIA, APRAXIA, CLONIC SPASMS, TREMOR, MUSCULAR WEAKNESS, DROPPING OF OBJECTS, INABILITY TO THINK CLEARLY &/OR HALLUCINATIONS SEEN IN 35 YR OLD PT WITH TERMINAL RENAL FAILURE TAKING 30 MG PIPERAZINE HEXAHYDRATE/KG BODY WT/DAY FOR 10 DAYS. /PIPERAZINE HEXAHYDRATE/SEVERE ILLNESS OCCURRED IN A 25 YR OLD WOMAN AFTER ADMIN OF PIPERAZINE ON 2 SEPARATE OCCASIONS. EVIDENCE FAVORS A HYPERSENSITIVITY MECHANISM RATHER THAN A DIRECT TOXIC EFFECT OF DRUG OR ITS METABOLITES. /PIPERAZINE/ACUTE HUMAN EXPOSURES HAVE RESULTED IN MILD TO MODERATE SKIN BURNS & SENSITIZATION. MILD TO MODERATE ASTHMA HAS BEEN ASSOCIATED WITH INHALATION OF DUST.
Non-Human Toxicity ExcerptsEYE CONTACT, MARKED PAIN AND MODERATE EYE IRRITATION WHICH HEALS IN 2 DAYS WITH NO CORNEAL INJURY. SKIN CONTACT VERY SLIGHT IRRITATION.VOMITING & DIARRHEA IS OCCASIONALLY REPORTED IN CATS & DOGS ESPECIALLY IF OVERDOSED. /ORAL ADMIN/IN ISOLATED FROG & RABBIT HEARTS PIPERAZINE PRODUCED BIPHASIC EFFECT WITH INITIAL NEG INOTROPIC ACTION FOLLOWED BY POS INOTROPIC ACTION. FORMER PHASE WAS ANTAGONIZED BY ATROPINE, HEXAMETHONIUM & DIGOXIN. DIRECT ACTION ON HEART IS SUGGESTED. /PIPERAZINE/
Non-Human Toxicity ValuesLD50 Rat oral 4,900 mg/kg
위험 문구(R)36/37/38-42/43
안전 문구(S)22-26-36/37/39-45